Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,238.00
+7.00 (0.57%)
Feb 19, 2026, 10:45 AM IDT

TLV:REKA Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
141151169176266306
Market Cap Growth
-11.31%-10.35%-3.96%-33.89%-13.13%34.20%
Enterprise Value
270295338321420441
Last Close Price
12.3113.2514.7815.3922.4025.79
PE Ratio
-24.37--40.1228.33
PS Ratio
0.470.470.520.601.011.15
PB Ratio
0.930.931.081.081.541.85
P/TBV Ratio
1.511.501.901.391.901.90
P/FCF Ratio
9.628.4710.015.4834.59-
P/OCF Ratio
6.695.705.954.5012.5527.11
EV/Sales Ratio
0.900.921.051.101.591.66
EV/EBITDA Ratio
93.7817.0513.007.8711.7310.86
EV/EBIT Ratio
--116.4324.2032.4921.10
EV/FCF Ratio
18.4916.5320.0710.0054.61-
Debt / Equity Ratio
0.900.831.181.020.961.00
Debt / EBITDA Ratio
45.885.335.614.074.644.10
Debt / FCF Ratio
9.287.5210.895.1721.59-
Net Debt / Equity Ratio
0.860.791.060.900.850.78
Net Debt / EBITDA Ratio
-26.357.346.313.574.123.19
Net Debt / FCF Ratio
8.877.129.744.5319.16-17.61
Asset Turnover
0.690.690.690.660.620.68
Inventory Turnover
2.482.792.562.352.122.36
Quick Ratio
0.900.901.011.061.301.17
Current Ratio
1.651.451.751.752.252.10
Return on Equity (ROE)
-8.96%3.91%-4.35%-1.22%3.91%6.73%
Return on Assets (ROA)
-4.04%-0.98%0.39%1.87%1.88%3.32%
Return on Invested Capital (ROIC)
-9.92%-1.89%0.93%-24.16%3.60%5.60%
Return on Capital Employed (ROCE)
-9.80%-2.50%0.90%4.30%3.80%6.70%
Earnings Yield
-10.04%4.10%-4.10%-1.16%2.49%3.53%
FCF Yield
10.40%11.80%9.99%18.25%2.89%-2.40%
Dividend Yield
----3.87%-
Buyback Yield / Dilution
-4.25%-----
Total Shareholder Return
-4.25%---3.87%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.